test

Craig Skaling

@Tcg Crossover Management, Llc

Latest period2024 - Q3ReportedManaged Assets$1.18BTotal holdings36
Assets growth rate23.02%Assets growth rate (2-Q avg)-0.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Tcg Crossover Management, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Tcg Crossover Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.18B in assets, with a quarterly growth rate of 23.02% and a 2-quarter average growth rate of -0.56%. The portfolio is managed by Craig Skaling, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
AVTEAerovate Therapeutics Inc
Recent Activity
0.4%
$4.683M
2.241M shares@ $2.1 avg price
AVTXAvalo Therapeutics Inc
Recent Activity
New Position
0.39%
$4.589M
483,000 shares@ $9.5 avg price
KODKodiak Sciences Inc
Recent Activity
Increased 12.02%
0.23%
$2.631M
1.008M shares@ $2.61 avg price
ANTXAn2 Therapeutics, Inc.
Recent Activity
0.15%
$1.664M
1.555M shares@ $1.07 avg price
VTYXVentyx Biosciences, Inc
Recent Activity
0.06%
$689,305
316,195 shares@ $2.18 avg price
CABACabaletta Bio, Inc
Recent Activity
0.04%
$409,672
86,795 shares@ $4.72 avg price